v3.22.4
Cover
Jan. 09, 2023
Cover [Abstract]  
Document Type 8-K
Document Period End Date Jan. 09, 2023
Entity Registrant Name Denali Therapeutics Inc.
Entity Incorporation, State or Country Code DE
Entity File Number 001-38311
Entity Tax Identification Number 46-3872213
Entity Address, Address Line One 161 Oyster Point Blvd.
Entity Address, City or Town South San Francisco
Entity Address, State or Province CA
Entity Address, Postal Zip Code 94080
City Area Code 650
Local Phone Number 866-8548
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Title of 12(b) Security Common Stock, par value $0.01 per share
Trading Symbol DNLI
Security Exchange Name NASDAQ
Entity Central Index Key 0001714899
Amendment Flag false